a) prostate specific antigen (PSA) is specific to the prostate but not to prostate cancer b) PSA cannot discriminate different cancer stages c) The introduction of PSA as a screening test has led to substantial 'overdiagnosis' d) PSA screening does not affect prostate cancer mortality
Should you have any comments or questions, please contact us.
webmaster(at)remove-this.urosource.com
UrosourceMr. E.N. van Kleffensstraat 5NL-6842 CV ARNHEMThe Netherlands
Phone: + 31 (0)26 389 06 80Fax: + 31 (0)26 389 06 74
